Atlas Trials

Recurrent Urethral Cancer

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Urethral Cancer

RecordFirmDate
Afatinib in Advanced Refractory Urothelial Cancer (NCT02122172)University of Chicago2017-09-13
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520)City of Hope Medical Center2013-10-01
Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer (NCT01639521)University of Southern California2013-05-01
Pazopanib in Treating Patients With Metastatic Urothelial Cancer (NCT00471536)National Cancer Institute (NCI)2008-08-01
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function (NCT00478361)M.D. Anderson Cancer Center2007-04-01
VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00407485)National Cancer Institute (NCI)2006-11-01
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium (NCT00112905)National Cancer Institute (NCI)2005-10-01
Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma (NCT00072150)National Cancer Institute (NCI)2003-10-01
Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00004856)National Cancer Institute (NCI)2002-07-01
Arsenic Trioxide in Treating Patients With Urothelial Cancer (NCT00009867)National Cancer Institute (NCI)2000-12-01
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074)National Cancer Institute (NCI)1999-08-01

Track Recurrent Urethral Cancer automatically

Every clearance here is in the API, with alerts when new ones post.